Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Carling

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Trends in Endocrinology and Metabolism: TEM|February 13, 2001
Molecular pathology of parathyroid tumorsT Carling
Journal of Internal Medicine|December 21, 2004
Parathyroid surgery in familial hyperparathyroid disordersT Carling, R Udelsman
Histology and Histopathology|May 16, 2000
Pathophysiology of primary hyperparathyroidismP Hellman, T Carling, L Rask, et al.
Lakartidningen|June 14, 2001
[Primary hyperparathyroidism is common among postmenopausal women. Identification of genetic risk factors can contribute to individualized treatment]P Correa, E Szabo, E Lundgren, et al.
Journal of Internal Medicine|November 20, 2016
Genetics of adrenocortical tumoursT Åkerström, T Carling, F Beuschlein, et al.
The Journal of Clinical Endocrinology and Metabolism|July 14, 1998
Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumorsT Carling, J Rastad, G Akerström, et al.
International Journal of Cancer|August 17, 1999
Analysis of the RAD54 gene on chromosome 1p as a potential tumor-suppressor gene in parathyroid adenomasT Carling, Y Imanishi, R D Gaz, et al.
The Science of the Total Environment|June 22, 2012
Dust-mediated loading of trace and major elements to Wasatch Mountain snowpackGregory T Carling, Diego P Fernandez, William P Johnson
Clinical Endocrinology|December 3, 1999
RAD51 as a candidate parathyroid tumour suppressor gene on chromosome 15q: absence of somatic mutationsT Carling, Y Imanishi, R D Gaz, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2000
Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidismT Carling, J Rastad, E Szabó, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Trends in Endocrinology and Metabolism: TEM|February 13, 2001
Molecular pathology of parathyroid tumorsT Carling
Journal of Internal Medicine|December 21, 2004
Parathyroid surgery in familial hyperparathyroid disordersT Carling, R Udelsman
Histology and Histopathology|May 16, 2000
Pathophysiology of primary hyperparathyroidismP Hellman, T Carling, L Rask, et al.
Lakartidningen|June 14, 2001
[Primary hyperparathyroidism is common among postmenopausal women. Identification of genetic risk factors can contribute to individualized treatment]P Correa, E Szabo, E Lundgren, et al.
Journal of Internal Medicine|November 20, 2016
Genetics of adrenocortical tumoursT Åkerström, T Carling, F Beuschlein, et al.
The Journal of Clinical Endocrinology and Metabolism|July 14, 1998
Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumorsT Carling, J Rastad, G Akerström, et al.
International Journal of Cancer|August 17, 1999
Analysis of the RAD54 gene on chromosome 1p as a potential tumor-suppressor gene in parathyroid adenomasT Carling, Y Imanishi, R D Gaz, et al.
The Science of the Total Environment|June 22, 2012
Dust-mediated loading of trace and major elements to Wasatch Mountain snowpackGregory T Carling, Diego P Fernandez, William P Johnson
Clinical Endocrinology|December 3, 1999
RAD51 as a candidate parathyroid tumour suppressor gene on chromosome 15q: absence of somatic mutationsT Carling, Y Imanishi, R D Gaz, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2000
Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidismT Carling, J Rastad, E Szabó, et al.
Pageof 4